Therapy: A local approach to Raynaud phenomenon
- PMID: 19412190
- DOI: 10.1038/nrrheum.2009.64
Therapy: A local approach to Raynaud phenomenon
Abstract
The current treatment options for Raynaud phenomenon are often ineffective and can have undesirable adverse effects. Topical, or transdermal, treatments that increase digital blood flow without systemic adverse effects are, therefore, an attractive option. A novel topical nitroglycerin formulation has shown promise in treating Raynaud attacks.
Comment on
-
MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial.Arthritis Rheum. 2009 Mar;60(3):870-7. doi: 10.1002/art.24351. Arthritis Rheum. 2009. PMID: 19248104 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
